Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 4Lymphoma, T-Cell, Cutaneous 4Leukemia-Lymphoma, Adult T-Cell 4Sezary Syndrome 3Neoplasms 3Mycosis Fungoides 3Carcinoma 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell 1Hematologic Neoplasms 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumors 1

Interventions

Dexamethasone 4nelarabine 3Calcium Dobesilate 2terameprocol 1ontuxizumab 1mogamulizumab 1isatuximab 1forodesine 1fludarabine phosphate 1fludarabine 1crenigacestat 1cobomarsen 1calaspargase pegol 1brincidofovir 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Sensitivity and Specificity 1Ranitidine 1Oxaliplatin 1Mycophenolic Acid 1Mesna 1Lenalidomide 1HBI-8000 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Fentanyl 1Diphenhydramine 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × mogamulizumab × Clear all
NCT01626664 2024-04-25

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

Kyowa Kirin Co., Ltd.

Phase 2 Completed
71 enrolled 15 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡